Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis

American Journal of Ophthalmology

Volumn 135, Issue 1, 2003, Pages 26-34

  Jabs, Douglas A ^a,b   Martin, Barbara K ^b   Forman, Michael S ^c   Hubbard, Larry ^e   Dunn, J P ^a   Kempen, John H ^a,b   Davis, Janet L ^d   Weinberg, David V ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE COURSE; EYE FUNDUS; FEMALE; FOLLOW UP; GENE MUTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IC 50; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PHOTOGRAPHY; PRIORITY JOURNAL; RETINITIS; RISK FACTOR; URINE CULTURE; VIRUS RESISTANCE; VISUAL ACUITY;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; BLOOD; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GANCICLOVIR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URINE;

EID: 0037215659     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01759-2     Document Type: Article

References (37)

1. Jabs D.A. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 93:1995;623-683.
2. Pertel P., Hirschtick R.E., Phair J., Chmiel J.S., Poggensee L., Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr. 5:1992;1069-1074.
3. Gallant J.E., Moore R.D., Richman D.D., Keruly J., Chaisson R.E. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis. 166:1992;1223-1227.
4. Hoover D.R., Peng Y., Saah A., et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 114:1996;821-827.
5. Jabs D.A., Bartlett J.G. AIDS and ophthalmology a period of transition . Am J Ophthalmol. 124:1997;227-233.
6. Palella F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 338:1998;853-860.
7. Holtzer C.D., Jacobson M.A., Hadley W.K., et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS. 12:1998;1931-1933.
8. Jacobson A.J., Stanley H., Holtzer C., Margolis T.P., Cunningham E.T. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis. 30:2000;232-233.
9. Jabs D.A., Enger C., Bartlett J.G. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 107:1989;75-80.
10. Jabs D.A., Enger C., Dunn J.P., Forman M. Cytomegalovirus resistance and viral resistance 4. Ganciclovir resistance . J Infect Dis. 177:1998;770-773.
11. Jabs D.A., Enger C., Forman M., Dunn J.P. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. Antimicrob Agents Chemother. 42:1998;2240-2244.
12. Dunn J.P., MacCumber M.W., Forman M.S., Charache P., Apuzzo L., Jabs D.A. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 119:1995;587-596.
13. Jabs D.A., Martin B.K., Forman M.S., et al. Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immune deficiency syndrome and cytomegalovirus retinitis the Cytomegalovirus and Viral Resistance Study Group Report Number 8 . Am J Ophthalmol. 132:2001;700-710.
14. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Ophthalmology. 101:1994;1250-1261.
15. Kuppermann B.D., Quiceno J.I., Flores-Aguilar M., et al. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis implications for therapy . J Infect Dis. 168:1993;1506-1509.
16. Arevalo J.F., Gonzalez C., Capparelli E.V. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis. 172:1995;951-956.
17. Enger C., Jabs D.A., Dunn J.P., et al. Viral resistance and CMV retinitis design and methods of a prospective study . Ophthalmic Epidemiol. 4:1997;41-48.
18. Jabs D.A., Enger C., Dunn J.P., Forman M., Hubbard L. Cytomegalovirus retinitis and viral resistance 3. Culture results . Am J Ophthalmol. 126:1998;543-549.
19. Dankner W.M., Scholl D., Stanat S.C., Martin M., Sonke R.L., Spector S.A. Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus. J Virol Method. 28:1990;293-298.
20. Jabs D.A., Dunn J.P., Enger C., Forman M., Bressler N., Charache C. Cytomegalovirus retinitis and viral resistance prevalence of resistance at diagnosis, 1994 . Arch Ophthalmol. 114:1996;809-814.
21. Drew W.L., Miner R.C., Busch D.F., et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 163:1991;716-719.
22. Drew W.L., Miner R.C., Saleh E. Antiviral susceptibility of cytomegalovirus criteria for detecting resistance to antivirals . Clin Diagn Virol. 1:1993;179-185.
23. Jabs D.A., Martin B.K., Forman M.S., et al. Mutations conferring ganciclovir resistance in a cohort of patients with AIDS and cytomegalovirus retinitis. J Infect Dis. 183:2001;333-337.
24. Combination foscarnet and ganciclovir therapy versus monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. Arch Ophthalmol. 114:1996;23-33.
25. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. J Infect Dis. 176:1997;50-58.
26. Jabs D.A., Bolton S.G., Dunn J.P., Palestine A.G. Discontinuing anti-CMV therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol. 126:1998;817-822.
27. Whitcup S.M., Fortin E., Lindblad S., et al. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA. 282:1999;1633-1637.
28. Torriani F.J., Freeman W.R., MacDonald J.C., et al. CMV retinitis recurs after stopping treatment in virological and immunologic failures of potent antiretroviral therapy. AIDS. 14:2000;173-180.
29. Musch D.C., Martin D.F., Gordon J.F., Davis M.D., Kuppermann B.D. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. N Engl J Med. 337:1997;83-90.
30. Martin D.F., Kuppermann B.D., Wolitz R.A., Palestine A.G., Li H., Robinson C.A. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med. 340:1999;1063-1070.
31. Liang K.Y., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika. 73:1986;13-22.
32. Andersen P.K., Gill R.D. Cox's regression model counting process a large sample study . Ann Statistics. 10:1982;1100-1120.
33. Hu H., Jabs D.A., Forman M.S., et al. Comparison of cytomegalovirus UL97 gene sequences in the blood and vitreous of patients with AIDS and cytomegalovirus retinitis. J Infect Dis. 185:2002;861-867.
34. Holbrook J.T., Meinert C.L., Van Natta M.L., Davis M., Hubbard L., Jabs D.A. Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients. Arch Ophthalmol. 119:2001;554-563.
35. Kempen J.H., Jabs D.A., Dunn J.P., West S.K., Tonascia J. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immune deficiency syndrome. Arch Ophthalmol. 119:2001;33-40.
36. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial . Am J Ophthalmol. 131:2001;457-467.
37. Jabs D.A., Forman M., Enger C., Jackson J.B. Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. J Clin Microbiol. 37:1999;1431-1435.